0001209191-16-094531.txt : 20160201 0001209191-16-094531.hdr.sgml : 20160201 20160201185512 ACCESSION NUMBER: 0001209191-16-094531 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160128 FILED AS OF DATE: 20160201 DATE AS OF CHANGE: 20160201 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Revance Therapeutics, Inc. CENTRAL INDEX KEY: 0001479290 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770551645 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7555 GATEWAY BLVD. CITY: NEWARK STATE: CA ZIP: 94560 BUSINESS PHONE: 510-742-3400 MAIL ADDRESS: STREET 1: 7555 GATEWAY BLVD. CITY: NEWARK STATE: CA ZIP: 94560 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SILVERNAIL LAUREN P CENTRAL INDEX KEY: 0001225755 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36297 FILM NUMBER: 161378767 MAIL ADDRESS: STREET 1: 15279 ALTON PARKWAY STREET 2: SUITE #100 CITY: IRVINE STATE: CA ZIP: 92618 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-01-28 0 0001479290 Revance Therapeutics, Inc. RVNC 0001225755 SILVERNAIL LAUREN P C/O REVANCE THERAPEUTICS, INC. 7555 GATEWAY BOULEVARD NEWARK CA 94560 0 1 0 0 CFO, CBO & Secretary Common Stock 2016-01-28 4 F 0 1063 20.30 D 21695 D Represents the number of shares withheld by and surrendered to the Issuer on January 28, 2016, to satisfy tax withholding obligations that arose in connection with the first annual installment of vesting of the Restricted Stock Award ("RSA") for 7,290 shares. The RSA vests in three equal annual installments from January 28, 2015, subject to Mrs. Silvernail's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) on each vesting date. /s/ Gordon Ho, Attorney-in-Fact 2016-02-01